Trials / Recruiting
RecruitingNCT05543798
VT Ablation in the iCMR
Vision-MR Ablation Catheter 2.0 for the Treatment of Ventricular Tachycardia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Imricor Medical Systems · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The VISABL-VT is a prospective, single-arm, multi-center, interventional investigation of the safety and efficacy of radiofrequency (RF) ablation of ventricular tachycardia associated with ischemic cardiomyopathy performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vision-MR Ablation Catheter 2.0 | Catheter ablation of ventricular tachycardia |
Timeline
- Start date
- 2025-04-10
- Primary completion
- 2026-12-01
- Completion
- 2027-06-01
- First posted
- 2022-09-16
- Last updated
- 2026-01-08
Locations
3 sites across 2 countries: Germany, Netherlands
Source: ClinicalTrials.gov record NCT05543798. Inclusion in this directory is not an endorsement.